Mads Laustsen
Executive Manager
Microbiology
symphogen
Denmark
Biography
Mr. Laustsen has more than 25 years of international experience within biologics development and manufacturing from CMC Biolog- ics, Novozymes, Zymogenetics and Novo. Mr. Laustsen co-founded CMC Biologics where he was the Chief Executive Officer and Chief Science Officer prior to joining Symphogen. Until March 1, 2017 Mr. Laustsen was a board member of CMC Biologics. Furthermore, he holds numerous patents related to biologics manufacturing and is on the Advisory Board of Institute of System Biology at the Danish Technical University..
Research Interest
His research interest lies in Microbiology
